Dexmedetomidine Hydrochlorid · 2,354 days since initial FDA posting
Brand: DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
FDA lists Dexmedetomidine Hydrochlorid as Active Shortage (Baxter Healthcare).
Availability on file: Unavailable
Dexmedetomidine Hydrochloride Injection: Active Shortage
Unavailable Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Dexmedetomidine Hydrochloride Injection
- Manufacturer
- Baxter Healthcare
- Dosage Form
- Injection
- Presentation
- Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 43066-557-12)
- Package NDC
- 43066-557-12
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Apr 10, 2020
- Last Updated
- Mar 4, 2026
- Therapeutic Category
- Anesthesia
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Estimated recovery: March 2026
Nearby, Other Dexmedetomidine Shortage Records
Dexmedetomidine Hydrochloride Injection
Gland Pharma Limited
Injection
Dexmedetomidine Hydrochloride Injection
Gland Pharma Limited
Injection
Dexmedetomidine Hydrochloride Injection
Gland Pharma Limited
Injection
Dexmedetomidine Hydrochloride Injection
Slayback Pharma
Injection
Dexmedetomidine Hydrochloride Injection
Slayback Pharma
Injection
Dexmedetomidine Hydrochloride Injection
Meitheal Pharmaceuticals, Inc.
Injection
FDA reason on file: Estimated recovery: March 2026. General shortage guidance lives on the tracker hub.